Patricia P.
- Country
- Portugal
- Department
- N/A
Research Overview
- A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Background of Methotrexate (MTX) and Who Have an Inadequate Response to MTX (MTX-IR)
- Phase 3 Randomized Double-blind Placebo-controlled Study of Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
- Evaluation of Cenerimod Efficacy and Safety in Adults with Moderate-to-Severe Systemic Lupus Erythematosus: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 76 of 265 partner sites.
Specializations
Rheumatoid Arthritis Research
The investigator demonstrates significant expertise in studying innovative treatments for rheumatoid arthritis (RA), with particular focus on evaluating novel therapeutic approaches for patients with inadequate response to conventional treatments.
- Subcutaneous administration therapies
- Methotrexate-based interventions
- Advanced therapeutic compounds
Areas of investigation include both traditional and emerging treatment modalities for managing moderate to severe RA symptoms.
Systemic Lupus Erythematosus Studies
The investigator conducts extensive research in systemic lupus erythematosus (SLE) treatment, focusing on novel therapeutic agents and their long-term effects in patients with moderate to severe disease manifestations.
- Disease activity reduction strategies
- Long-term safety assessments
- Background therapy optimization
Research encompasses both innovative compounds and established treatment protocols for SLE management.
Autoimmune Disorders
The investigator explores treatments for various autoimmune conditions, including Primary Sjögren's Disease, focusing on systemic disease activity and innovative biological therapies.
- Systemic disease management
- Novel biological interventions
- Subcutaneous treatment delivery
Research activities center on developing effective therapeutic strategies for complex autoimmune manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.